ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 670162 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 670162; 2) Community: the network communities that were significantly associated with the response to NSC 670162; 3) Molecule: the relationships between components within communities and NSC 670162; 4) MDR: the compounds that were significantly associated with the NSC 670162.

NSC Compound Enrichment Correlation
NSC 737147 2-(4-Chloroanilino)-N'-[(4-acetylaminophenyl)sulphonyl]nicotino hydrazide 0.0422011701988039 0.18727445
NSC 748146 5-bromo-2-{[(2)-3-phenylprop-2-enoyl]amino}benzamide 0.0422011701988039 0.02947816
NSC 750762 2-methoxy-7-benzyl-3-(phenylsulfonyl)-6,7-dihydro-5H-pyrazolo[3,4-h]quinoline 0.0422011701988039 0.012596458
NSC 758706 Simvastatin (USAN) 0.0422011701988039 -0.0011454414
NSC 87500 Solacongestidine 0.0422011701988039 0.17066543
NSC 686560 [Di-17.alpha./.beta.-(2-ethoxy-3-hydroxyestra-1,3,5(10)-triene)-]sulphite 0.0422011701988042 0.013581269
NSC 81052 Streptonigrin analog (MeO-N3) 0.0422011701988042 0.032478411
NSC 105827 SANGIVAMYCIN,-THIO 0.0438391811600409 0.060948447
NSC 228120 Benzofurazan, 4-[(3-methoxyphenyl)thio]-7-nitro-, 3-oxide 0.0438391811600409 -0.031314896
NSC 292816 1-Butanone, 1,1'-(9-ethyl-9H-carbazole-3,6-diyl)bis[4-(dimethylamino)-, (E)-2-butenedioate (1:1) 0.0438391811600409 0.092268317
Total:43  Current:32    [First] [Prev] [Next] [Last]